Search results
PowerPoint slide set summarizing GOLD’s objectives, documents, and management recommendations from the 2024 update of the GOLD Report, with background information about COPD and the burden of this disease.
The GOLD update includes a table that combines two recent taxonomic proposals developed independently to highlight etiotypes of COPD.2,6,7 These etiotypes in-clude genetically determined COPD, such as that caused by AATD; COPD due to abnormal lung devel-opment, such as that resulting from premature birth; environmental COPD, including disease re...
chapters included in the 2024 document are as follows: • Chapter 1: Definition and Overview • Chapter 2: Diagnosis and Assessment • Chapter 3: Prevention and Management of COPD • Chapter 4: Management of Exacerbations • Chapter 5: COPD and Comorbidities • Chapter 6: COVID-19 and COPD
GOLD 2024 continues to propose that a post-bronchodilator FEV 1 /FVC<0.7, in the appropriate clinical context, is mandatory to establish the diagnosis of COPD. 2 However, we also recognize that there is an ongoing, and not yet resolved, debate on two key aspects of this proposal.
4 lip 2024 · Key updates in 2024 GOLD COPD report 1,2 Key changes in the latest report include an update on blood eosinophil count based treatment recommendations in the initial assessment section and revisions to smoking cessation section under prevention and management of COPD.
4 gru 2023 · The 2024 report from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD) has been published.
GOLD 2024 continues to propose that a post-bronchodilator FEV1/FVC<0.7, in the appropriate clinical context, is mandatory to establish the diagnosis of COPD. However, we also recognize that there is an ongoing, and not yet resolved, debate on two key aspects of this proposal.
